Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome 26S subunit, non-ATPase 14 (PSMD14) is a zinc-dependent metalloprotease and a critical deubiquitinating enzyme within the 19S regulatory particle of the 26S proteasome, responsible for removing polyubiquitin chains from targeted substrates prior to their degradation by the proteasome’s 20S core. This function is essential for regulated protein turnover, cellular homeostasis, and quality control. PSMD14 specifically recognizes and cleaves Lys-63-linked ubiquitin chains and thereby regulates diverse cellular processes, including cell cycle progression, apoptosis, DNA double-strand break repair, and multiple oncogenic signaling pathways. Aberrant activity or expression of PSMD14 has been implicated in cancer progression, multidrug resistance, and neurodegenerative disorders. While PSMD14 is considered a promising therapeutic target—especially for certain cancers—no selective, clinically approved inhibitors exist as of 2024, and broad proteasome inhibition can lead to significant toxicity due to interference with essential cellular protein degradation
Inhibition of PSMD14’s deubiquitinase (metalloprotease) activity prevents deubiquitination and leads to accumulation of polyubiquitinated proteins, impaired proteasomal degradation, cell cycle arrest, and apoptosis, with anti-tumor effects in preclinical models
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, non-ATPase 14 (PSMD14).